Skip to main content
. 2019 Oct 10;36(4):301–309. doi: 10.5114/biolsport.2019.88752

TABLE 1.

Summary of primary data for association between PPARGC1A Gly482Ser polymorphism and endurance performance.

Authors Year Country Ethnicity Group Number (N) Genotype (N) MAF PHWE NOS Score
Gly/Gly Gly/Ser Ser/Ser
Lucia et al. 2005 Spain Caucasian Case Control 104 52 43 9 0.293 1.0000 7
100 36 48 16 0.400
Eynon et al. 2010 Israeli Caucasian Case Control 74 37 37 0 0.250 0.9529 7
240 79 117 44 0.427
Muniesa et al. 2010 Spanish Caucasian Case Control 141 65 52 24 0.355 0.2261 7
123 47 63 13 0.362
Ginevičienė et al. 2011 Lithuanian Caucasian Case Control 77 40 33 4 0.266 0.5177 9
250 129 104 17 0.276
Maciejewska et al. 2012 Polish Caucasian Case Control 84 46 34 4 0.250 0.8938 8
684 280 314 90 0.361
Russian Caucasian Case Control 548 273 239 36 0.284 0.6651
1132 489 505 138 0.345
He et al. 2015 Chinese Asian Case Control 235 73 115 47 0.445 0.6321 7
504 156 244 104 0.448
Yvert et al. 2016 Japanese Asian Case Control 175 45 87 43 0.494 0.8741 8
649 191 324 134 0.456
Peplonska et al. 2017 Polish Caucasian Case Control 225 102 105 18 0.313 0.0871 6
451 199 213 39 0.323
Guilherme et al. 2018 Brazilian Caucasian Case Control 316 153 140 23 0.294 0.6187 7
893 428 385 80 0.305

MAF = minor allele frequency, P HWE = P value for Hardy–Weinberg equilibrium of controls, NOS = Newcastle-Ottawa Scale.